Nanobiotix SA GAAP每股收益-0.11欧元，收入2，660万欧元

2025-10-01 22:07

More on Nanobiotix

Nanobiotix: Today's Data Readout For Radiation Therapy Enhances Bull Case
Nanobiotix S.A. (NBTX) Discusses on New Phase 1 Results In Metastatic Melanoma Conference
Nanobiotix S.A. (NBTX) Discusses On New Phase 1 Results In Metastatic Melanoma Conference (Transcript)
Nanobiotix soars on positive phase 1 results for JNJ-1900 in melanoma
Seeking Alpha’s Quant Rating on Nanobiotix